Real‐world patient experience with erenumab for the preventive treatment of migraine

J Robblee, KL Devick, N Mendez… - … : The Journal of …, 2020 - Wiley Online Library
Background Erenumab, a calcitonin gene‐related peptide (CGRP) receptor monoclonal
antibody, has been well tolerated with good efficacy for the preventive treatment of episodic …
被引用次数：96 相关文章

Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine

J Robblee, KL Devick, N Mendez, J Potter… - …, 2020 - mayoclinic.elsevierpure.com
Background: Erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal
antibody, has been well tolerated with good efficacy for the preventive treatment of episodic …

Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine

J Robblee, KL Devick, N Mendez, J Potter… - …, 2020 - mayoclinic.pure.elsevier.com
Background: Erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal
antibody, has been well tolerated with good efficacy for the preventive treatment of episodic …

Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.

J Robblee, KL Devick, N Mendez, J Potter, J Slonaker… - Headache, 2020 - europepmc.org
Background Erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal
antibody, has been well tolerated with good efficacy for the preventive treatment of episodic …

Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine

J Robblee, KL Devick, N Mendez, J Potter… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal
antibody, has been well tolerated with good efficacy for the preventive treatment of episodic …